title: Advanced heart failure and management strategies.
abstract: The global healthcare burden attributable to heart failure is ever increasing. Patients presenting with refractory heart failure should be evaluated for compliance with medical regimens and sodium and/or fluid restriction, and every attempt should be made to optimize conventional strategies. Reversible causes such as ischemia should be identified and revascularization considered in persistently symptomatic patients, particularly those with a viable myocardium. Carefully selected patients who continue to deteriorate clinically in spite of optimization of medical therapy may be considered for advanced treatment strategies, such as continuous inotropic infusions, mechanical circulatory support devices, cardiac transplantation, or referral to hospice care. We discuss the clinical presentation and management of patients with advanced/refractory (Stage D) heart failure.
authors: Department of Cardiology, Ochsner Clinic Foundation, New Orleans, LA.
authors: Krishna K
authors: KK
authors: Gaddam
authors: Pridhvi
authors: P
authors: Yelamanchili
authors: Yabiz
authors: Y
authors: Sedghi
authors: Hector O
authors: HO
authors: Ventura
references: Am Heart J. 1991 Jun;121(6 Pt 2):1956-64
references: 2035427
references: Circulation. 2006 Feb 7;113(5):671-8
references: 16461840
references: J Am Coll Cardiol. 2004 Mar 3;43(5):787-93
references: 14998618
references: N Engl J Med. 2004 Nov 11;351(20):2049-57
references: 15533851
references: N Engl J Med. 1999 Sep 2;341(10):709-17
references: 10471456
references: J Heart Lung Transplant. 2004 Apr;23(4):466-72
references: 15063407
references: J Heart Lung Transplant. 2004 Sep;23(9):1082-6
references: 15454175
references: J Heart Lung Transplant. 2008 Sep;27(9):943-56
references: 18765186
references: N Engl J Med. 2005 Jan 20;352(3):225-37
references: 15659722
references: Circulation. 2005 May 17;111(19):2454-60
references: 15867182
references: N Engl J Med. 2002 Mar 21;346(12):877-83
references: 11907286
references: N Engl J Med. 1997 Feb 20;336(8):525-33
references: 9036306
references: N Engl J Med. 2005 Apr 14;352(15):1539-49
references: 15753115
references: J Am Coll Cardiol. 2009 Apr 14;53(15):e1-e90
references: 19358937
references: N Engl J Med. 2001 Nov 15;345(20):1435-43
references: 11794191
references: Circulation. 1997 Jun 17;95(12):2660-7
references: 9193435
references: J Am Coll Cardiol. 2007 Feb 13;49(6):675-83
references: 17291932
references: N Engl J Med. 2003 Apr 3;348(14):1309-21
references: 12668699
references: Circulation. 2008 Jan 29;117(4):e25-146
references: 18086926
references: J Am Coll Cardiol. 2008 Jul 29;52(5):347-56
references: 18652942
references: J Am Coll Cardiol. 2005 Dec 6;46(11):2043-6
references: 16325039
references: Am Heart J. 1999 Aug;138(2 Pt 1):241-6
references: 10426834
references: J Card Fail. 2004 Jun;10(3):200-9
references: 15190529
references: N Engl J Med. 2004 May 20;350(21):2140-50
references: 15152059
references: Am J Cardiol. 1997 Jul 1;80(1):61-4
references: 9205021
references: N Engl J Med. 1998 Nov 19;339(21):1522-33
references: 9819452
references: J Heart Lung Transplant. 2006 Sep;25(9):1024-42
references: 16962464
references: Circulation. 2006 Mar 21;113(11):1424-33
references: 16534009